Table 1. Clinical characteristics of patients with gastric in TCGA and validated cohort.
Variable | TCGA | Validated cohort | |||
---|---|---|---|---|---|
N | % | N | % | ||
Sex | |||||
male | 234 | 65.0 | 122 | 54.0 | |
female | 126 | 35.0 | 104 | 46.0 | |
Age | 65 | 30–90 | 58 | 19–82 | |
Primary site | |||||
Antrum/Distal | 137 | 38.1 | 84 | 37.2 | |
Cardia/Proximal | 48 | 13.3 | 77 | 34.1 | |
Fundus/Body | 132 | 36.7 | 44 | 19.5 | |
Gastroesophageal Junction | 37 | 10.3 | 21 | 9.3 | |
Unspecific | 6 | 1.7 | 0 | 0 | |
Grade | |||||
G1/G2 | 133 | 36.9 | 96 | 42.5 | |
G3 | 218 | 60.6 | 126 | 55.8 | |
Gx | 9 | 2.5 | 4 | 1.8 | |
T stage | |||||
T1 | 17 | 4.7 | 3 | 1.3 | |
T2 | 70 | 19.4 | 32 | 14.2 | |
T3 | 167 | 46.4 | 100 | 44.2 | |
T4 | 105 | 29.2 | 91 | 40.3 | |
Tx | 1 | 0.3 | 0 | 0 | |
N stage | |||||
N0 | 113 | 31.4 | 62 | 27.4 | |
N1 | 94 | 26.1 | 50 | 22.1 | |
N2 | 72 | 20.0 | 50 | 22.1 | |
N3 | 75 | 20.8 | 64 | 28.3 | |
Nx | 6 | 1.7 | 0 | 0 | |
M stage | |||||
M0 | 328 | 91.1 | 226 | 100 | |
M1 | 18 | 5.0 | 0 | 0 | |
Mx | 14 | 3.9 | 0 | 0 |